Reviva Pharmaceuticals Holdings annual operating expenses
2019
2019
2020
2020
2021
2021
2022
2023
2024
2025
Reviva Pharmaceuticals Holdings Operating Expenses Growth & History (RVPH)
Reviva Pharmaceuticals Holdings's operating expenses was $20.2M for fiscal 2025.
View full Reviva Pharmaceuticals Holdings company overviewReviva Pharmaceuticals Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20.2M | −$10.6M | −34.41% |
| 2024 | 2024-12-31 | $30.8M | −$8.7M | −22.04% |
| 2023 | 2023-12-31 | $39.5M | $11.3M | +39.94% |
| 2022 | 2022-12-31 | $28.2M | — | — |
| 2021 · Dec 31 | 2021-12-31 | $10.1M | $7.7M | +315.03% |
| 2021 · Dec 13 | 2021-12-13 | $10.1M | $7.7M | +315.03% |
| 2020 · Dec 31 | 2020-12-31 | $2.4M | $2.1M | +546.04% |
| 2020 · Feb 29 | 2020-02-29 | $724,740 | $571,951 | +374.34% |
| 2019 · Dec 31 | 2019-12-31 | $376,860 | — | — |
| 2019 · Feb 28 | 2019-02-28 | $152,789 | — | — |
Reviva Pharmaceuticals Holdings quarterly operating expenses
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.20
Q1.21
Q1.21
Q2.21
Q2.21
Q3.21
Q1.21
Q2.21
Q3.21
Q4.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.6M | −$3.5M | −56.90% |
| Q1 2026 | 2026-03-31 | $3.3M | −$3.3M | −49.96% |
| Q4 2025 | 2025-12-31 | $3.6M | −$2.7M | −43.37% |
| Q3 2025 | 2025-09-30 | $4.0M | −$4.4M | −52.38% |
| Q2 2025 | 2025-06-30 | $6.1M | −$2.1M | −25.30% |
| Q1 2025 | 2025-03-31 | $6.5M | −$1.4M | −17.47% |
| Q4 2024 | 2024-12-31 | $6.3M | −$3.3M | −34.67% |
| Q3 2024 | 2024-09-30 | $8.5M | −$3.1M | −26.82% |
| Q2 2024 | 2024-06-30 | $8.1M | −$3.2M | −28.28% |
| Q1 2024 | 2024-03-31 | $7.9M | $937,407 | +13.42% |
| Q4 2023 | 2023-12-31 | $9.6M | −$141,852 | −1.45% |
| Q3 2023 | 2023-09-30 | $11.6M | $6.1M | +110.33% |
| Q2 2023 | 2023-06-30 | $11.3M | $5.8M | +105.37% |
| Q1 2023 | 2023-03-31 | $7.0M | −$465,458 | −6.25% |
| Q4 2022 | 2022-12-31 | $9.8M | — | — |
| Q3 2022 | 2022-09-30 | $5.5M | $3.0M | +121.97% |
| Q2 2022 | 2022-06-30 | $5.5M | $3.7M | +208.33% |
| Q1 2022 | 2022-03-31 | $7.5M | $5.6M | +297.95% |
| Q4 2021 | 2021-12-31 | $4.0M | — | — |
| Q4 2021 | 2021-12-13 | $4.0M | $3.6M | +1026.52% |
| Q3 2021 · Sep 30 | 2021-09-30 | $2.5M | $2.0M | +383.48% |
| Q2 2021 · Jun 30 | 2021-06-30 | $1.8M | $1.0M | +130.27% |
| Q1 2021 · Mar 31 | 2021-03-31 | $1.9M | $1.3M | +202.80% |
| Q3 2021 · Nov 30 | 2020-11-30 | $352,007 | $185,985 | +112.02% |
| Q2 2021 · Sep 30 | 2020-09-30 | $512,291 | — | — |
| Q2 2021 · Aug 31 | 2020-08-31 | $525,924 | $431,814 | +458.84% |
| Q1 2021 · Jun 30 | 2020-06-30 | $777,384 | — | — |
| Q1 2021 · May 31 | 2020-05-31 | $264,941 | $193,806 | +272.45% |
| Q1 2020 · Mar 31 | 2020-03-31 | $618,277 | — | — |
| Q4 2020 | 2020-02-29 | $393,473 | $335,499 | +578.71% |
| Q3 2020 | 2019-11-30 | $166,022 | $86,876 | +109.77% |
| Q2 2020 | 2019-08-31 | $94,110 | $91,782 | +3942.53% |
| Q1 2020 · May 31 | 2019-05-31 | $71,135 | $57,794 | +433.21% |
| Q4 2019 | 2019-02-28 | $57,974 | — | — |
| Q3 2019 | 2018-11-30 | $79,146 | — | — |
| Q2 2019 | 2018-08-31 | $2,328 | — | — |
| Q1 2019 | 2018-05-31 | $13,341 | — | — |
Reviva Pharmaceuticals Holdings operating expenses trends
Over the last five fiscal years, Reviva Pharmaceuticals Holdings's operating expenses increased from $2.4M to $20.2M, a change of $17.8M. The latest reported quarter, Q2 2026, shows $2.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Reviva Pharmaceuticals Holdings source filings ↗